✦ LIBER ✦

Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade

✍ Scribed by Jeffrey Weber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

At the Bench: Preclinical rationale for

✍ Intlekofer, A. M.; Thompson, C. B. 📂 Article 📅 2013 🏛 Society for Leukocyte Biology 🌐 English ⚖ 497 KB

CTLA-4 and PD-1/PD-L1 Blockade: New Immu

✍ Ott, P. A.; Hodi, F. S.; Robert, C. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 938 KB